CHEK2 and neoplasm: At the tumor-specific resistance level, genomic aberrations affecting tumorsuppressor genes such as ATM, PTEN, P53, LKB1, and CHEK2 have been reported, allowing tumor cells to bypass cellcycle checkpoints and proliferate uncontrollably.